Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|
Total reported revenue | 2.5T | 2.3T | 2.6T |
Cost of revenue | 1.8T | 1.6T | 2.0T |
Gross profit | 719.3B | 633.2B | 655.1B |
Operating expense | |||
Research & development | — | — | — |
Selling general and admin | 489.2B | 433.0B | 460.2B |
Other operating expenses | — | — | — |
Operating income | 230.1B | 200.2B | 194.9B |
Non operating interest income | |||
Income | 8.8B | 10.3B | 8.5B |
Expense | 16.0B | 17.3B | 19.9B |
Other income expense | — | — | — |
Pretax income | 183.7B | 320.1B | 206.6B |
Tax provision | 33.5B | 75.9B | 55.9B |
Net income | 150.2B | 244.2B | 150.7B |
Basic EPS | — | — | — |
Diluted EPS | — | — | — |
Basic average shares | — | — | — |
Diluted average shares | — | — | — |
EBITDA | 300.7B | 440.9B | 352.2B |
Net income from continuing op. | 150.2B | 244.2B | 150.7B |
Minority interests | -5.4B | -8.2B | -11.6B |
Preferred stock dividends | 0 | 0 | 0 |